Factors linked to pregnancy after IUI treatment
Part of Women’s health & pregnancy clinical trials.
This study looks at what factors help predict a successful pregnancy in people who have undergone intrauterine insemination (IUI). It may help doctors better understand and improve IUI success rates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You and your partner must have had at least one IUI treatment cycle.
- You must not have used donor sperm during IUI treatment.
- Your treatment records must include all key outcome information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood-derived treatment called PRP (platelet-rich plasma) can improve pregnancy chances when used alongside intrauterine insemination (IUI), a fertility procedure where sperm is placed directly into the uterus. The study evaluates whether this approach is safe and effective for women seeking fertility treatment.
This trial tests whether mixing a woman's platelet-rich plasma (a concentration of your own blood cells that help healing) with her husband's sperm before an IUI procedure can improve pregnancy chances. It's for women getting IUI who meet specific health and age requirements.
This trial tests a new AI system that analyzes sperm to predict how well they might work in fertility treatments like IVF or ICSI. It aims to help doctors choose the best sperm for a successful pregnancy.
This study tests whether intrauterine insemination (IUI), a simple procedure where sperm is placed directly into the uterus, improves the chance of a successful pregnancy for couples who have had at least one unexplained miscarriage. It aims to help couples who are trying again within a year of their loss.
This study tests whether adding support in the period after ovulation (the “luteal phase”) helps people who are starting IUI (intrauterine insemination) because their infertility is unexplained. It’s designed to see if the added care improves chances when mild ovarian stimulation is used.
This study compares two ways of timing intrauterine insemination (IUI)—using letrozole medicine to help schedule ovulation versus using a natural (untreated) cycle. It may help couples who are trying to conceive with mild or “unexplained” infertility see which approach works better for pregnancy chances.
Hear when a new Reproductive Issues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.